Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hengkang Medical Group Co Ltd

+ Add to Watchlist

002219:CH

42.700 CNY 1.000 2.29%

As of 03:00:28 ET on 05/22/2015.

Snapshot for Hengkang Medical Group Co Ltd (002219)

Open: 43.900 Day's Range: 42.100 - 44.100 Volume: 10,053,383
Previous Close: 43.700 52wk Range: 18.250 - 44.790 1-Yr Rtn: +121.24%

Stock Chart for 002219

No chart data available.
  • 002219:CH 42.700
  • 1D
  • 1M
  • 1Y
43.700
Interactive 002219 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002219

Current P/E Ratio (ttm) 111.4010
Estimated P/E(12/2015) 71.1667
Relative P/E vs. SZASHR 1.6393
Earnings Per Share (CNY) (ttm) 0.3833
Est. EPS (CNY) (12/2015) 0.6000
Est. PEG Ratio -
Market Cap (M CNY) 26,317.25
Shares Outstanding (M) 616.33
30 Day Average Volume 10,796,400
Price/Book (mrq) 24.5308
Price/Sale (ttm) 38.8757
Dividend Indicated Gross Yield -%
Cash Dividend (CNY) 0.0714
Dividend Ex-Date 02/28/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002219

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002219

HengKang Medial Group engages in the R&D, manufacturing, and sales of pharmaceuticals then further expanded its operations to retail health products and provide health care services through the acquisition of hospitals.

Duan ZhipingChairmanXie HaiPresident
Zuo BinlinExecutive Vice PresidentLi XuefengVice President
More Company Profile & Key Executives for 002219

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil